Czarnota G J, Kolios M C, Abraham J, Portnoy M, Ottensmeyer F P, Hunt J W, Sherar M D
Ontario Cancer Institute and Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Canada.
Br J Cancer. 1999 Oct;81(3):520-7. doi: 10.1038/sj.bjc.6690724.
A new non-invasive method for monitoring apoptosis has been developed using high frequency (40 MHz) ultrasound imaging. Conventional ultrasound backscatter imaging techniques were used to observe apoptosis occurring in response to anticancer agents in cells in vitro, in tissues ex vivo and in live animals. The mechanism behind this ultrasonic detection was identified experimentally to be the subcellular nuclear changes, condensation followed by fragmentation, that cells undergo during apoptosis. These changes dramatically increase the high frequency ultrasound scattering efficiency of apoptotic cells over normal cells (25- to 50-fold change in intensity). The result is that areas of tissue undergoing apoptosis become much brighter in comparison to surrounding viable tissues. The results provide a framework for the possibility of using high frequency ultrasound imaging in the future to non-invasively monitor the effects of chemotherapeutic agents and other anticancer treatments in experimental animal systems and in patients.
一种使用高频(40兆赫)超声成像监测细胞凋亡的新的非侵入性方法已经研发出来。传统的超声背向散射成像技术被用于观察体外细胞、离体组织和活体动物体内因抗癌药物而发生的细胞凋亡。通过实验确定这种超声检测背后的机制是细胞在凋亡过程中经历的亚细胞核变化,即核浓缩随后核碎裂。这些变化极大地提高了凋亡细胞相对于正常细胞的高频超声散射效率(强度变化25至50倍)。结果是,与周围的存活组织相比,发生凋亡的组织区域变得亮得多。这些结果为未来在实验动物系统和患者中使用高频超声成像非侵入性监测化疗药物和其他抗癌治疗效果的可能性提供了一个框架。